Adherence to colonoscopy at 1 year following resection of localized colon cancer: a retrospective cohort study

Neugut, Alfred I.; Zhong, Xiaobo; Lebwohl, Benjamin; Hillyer, Grace Clarke; Accordino, Melissa K.; Wright, Jason D.; Kiran, Ravi P.; Hershman, Dawn L.

doi:10.1177/1756284818765920

Cited by 8 publications

(9 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Blacks had lower receipt of surveillance colonoscopy than NHWs, and this may contribute to the poorer CRC survival among Black patients 12,19 . Other studies with larger samples of minorities have suggested that Hispanics are less likely to receive surveillance; however, we found no statistically significant difference between Hispanics and NHWs 20 …”

Section: Discussioncontrasting

confidence: 74%

See 1 more Smart Citation

Inequitable access to surveillance colonoscopy among Medicare beneficiaries with surgically resected colorectal cancer

Sanchez

Shankaran

Unger

et al. 2020

Cancer

View full text Add to dashboard Cite

BackgroundAfter colorectal cancer (CRC) surgery, surveillance with colonoscopy is an important step for the early detection of local recurrence. Unfortunately, surveillance colonoscopy is underused, especially among racial/ethnic minorities. This study assesses the association between patient and neighborhood factors and receipt of surveillance colonoscopy.MethodsThis retrospective, population‐based cohort study used Surveillance, Epidemiology, and End Results–Medicare linked data (2009‐2014). Beneficiaries with surgically resected stage II or III CRC between the ages of 66 and 85 years were identified, and multivariable logistic regression was used to assess the effect of factors on receipt of colonoscopy.ResultsOverall, 57.5% of the patients received initial surveillance colonoscopy. After adjustments for all factors, Blacks and Hispanics had lower odds of receiving colonoscopy than non‐Hispanic Whites (NHWs; 29.6% for Blacks; P = .002; 12.9% for Hispanics; P > .05). NHWs with Medicaid coverage had 35% lower odds of surveillance colonoscopy than NHWs without Medicaid coverage. Minority patients with Medicaid were more likely to receive colonoscopy than their racial/ethnic counterparts without Medicaid coverage (P > .05). Hispanics residing in neighborhoods with incomes of ≥$90,000 had significantly lower odds of surveillance colonoscopy than Hispanics residing in neighborhoods with incomes of $0 to $30,000.ConclusionsReceipt of initial surveillance colonoscopy remains low, and there are acute disparities between Black and NHW patients. The association between factors that assess a patient's ability to access colonoscopy and actual receipt of colonoscopy suggests inequitable access to surveillance colonoscopy within and across racial/ethnic groups.

show abstract

Section: Discussioncontrasting

confidence: 74%

“…Neighborhood socioeconomic determinants contribute to racial/ethnic disparities in receipt of cancer‐related outcomes 12,20 . A key finding was that Hispanics residing in neighborhoods with an MHI of ≥$90,001 had significantly lower odds of surveillance colonoscopy than Hispanics residing in neighborhoods with lower MHIs.…”

Section: Discussionmentioning

confidence: 99%

Inequitable access to surveillance colonoscopy among Medicare beneficiaries with surgically resected colorectal cancer

Sanchez

Shankaran

Unger

et al. 2020

Cancer

View full text Add to dashboard Cite

show abstract

“…Research studies have highlighted that individuals from medically underserved populations are less likely to receive counseling to complete screening, 23 have less access to preventive care and CRC treatment after diagnosis, 24 are less likely to complete diagnostic colonoscopy after abnormal FIT, 20 and are also less likely to receive colonoscopy surveillance after curative CRC treatment. 25 26 Given the impact of COVID-19 on our research activities, we propose the following solutions for individuals facing similar challenges ( Table 1 ).…”

Section: Crc Research In the Underservedmentioning

confidence: 99%

Impact of COVID-19 on colorectal cancer disparities and the way forward

Balzora

Issaka

Anyane‐Yeboa

et al. 2020

Gastrointestinal Endoscopy

View full text Add to dashboard Cite

In response to the coronavirus disease 2019 (COVID-19) pandemic, the U.S. Surgeon General advised all hospitals and ambulatory care centers to delay nonurgent medical procedures and surgeries. This recommendation, echoed by a multigastroenterology society guideline, led to the suspension of colonoscopies for colorectal cancer (CRC) screening and surveillance. Although this temporary suspension was necessary to contain COVID-19 infections, we as gastroenterologists, patient advocates, and CRC researchers have witnessed the downstream impact of COVID-19 and this recommendation on CRC screening, research, and advocacy. These effects are particularly noticeable in medically underserved communities where CRC morbidity and mortality are highest. COVID-19related pauses in medical care, as well as shifts in resource allocation and workforce deployment, threaten decades worth of work to improve CRC disparities in medically underserved populations. In this perspective, we present the unique challenges COVID-19 poses to health equity in CRC prevention and provide potential solutions as we navigate these uncharted waters.

show abstract

“…26,27 Various studies have shown that sex, age, length of hospital stay, histopathological grading and stages of cancer, number of medications, co-morbidity, and complications are determinants of DRP development. 22,24,28,29 A comprehensive study of DRPs would provide valuable insight for healthcare providers to reduce the incidence of DRPs and improve treatment outcomes in cancer patients. 30 DRPs can be prevented and managed with clinical pharmacists.…”

Section: Introductionmentioning

confidence: 99%

Clinical pattern and drug-related problems among colorectal cancer patients at oncology center in Ethiopia: A hospital-based study

et al. 2022

View full text Add to dashboard Cite

Objective: Despite the fact that cancer patients are highly susceptible to drug-related problems due to the effects of cytotoxic agents, data are limited due to a lack of studies on those patients. Hence, we aimed to investigate drug-related problems among patients diagnosed with colorectal cancer. Method: A registry-based cross-sectional study was conducted on colorectal cancer patients at the Felege Hiwot Comprehensive Specialized Hospital. Socio-demographic and disease-related characteristics, treatment regimens, and drug-related problems were recorded by reviewing medical records. Standard guidelines, protocols, and databases were used to evaluate the occurrence of drug-related problems and the severity of adverse drug reactions. For the analysis, Stata version 16/MP for Windows was used. Logistic regression analysis was employed to investigate the potential-associated factors of drug-related problems. A p-value ⩽ 0.05 was used to declare the statistical significance of each independent variable. Results: A total of 150 colorectal cancer patients were included, with a mean age of 51.4 ± 13.8 years. About 30% and 41.3% had stage II and stage III cancers, respectively. About three-quarters (73.8%) of the patients were given 5-fluorouracil-based combination regimens. The prevalence of drug-related problems was found to be 48.7%, with a mean of 2.12 ± 0.93 drug-related problems. In the Felege Hiwot Comprehensive Specialized Hospital, drug–drug interactions and adverse drug reactions were the most prevalent drug-related problems, which accounted for 50 (32.7%) and 49 (32%) cases, respectively. Being elderly (>50 years old) ( p = 0.013), having co-morbidity ( p = 0.001), and being on five or more medications ( p = 0.002) were independent predictors of drug-related problems. Conclusion: Fluorouracil-based chemotherapy was the most frequently used treatment regimen. Almost, half of the colorectal cancer patients had one or more drug-related problems. About one-third of patients had adverse drug reactions and drug–drug interactions. Furthermore, age, co-morbidity status, and the number of medications used were significantly associated with drug-related problems. Clinical pharmacy services should be implemented to optimize drug therapy because the majority of colorectal cancer patients have one or more drug-related problems.

show abstract

Adherence to colonoscopy at 1 year following resection of localized colon cancer: a retrospective cohort study

Cited by 8 publications

References 47 publications

Inequitable access to surveillance colonoscopy among Medicare beneficiaries with surgically resected colorectal cancer

Inequitable access to surveillance colonoscopy among Medicare beneficiaries with surgically resected colorectal cancer

Impact of COVID-19 on colorectal cancer disparities and the way forward

Clinical pattern and drug-related problems among colorectal cancer patients at oncology center in Ethiopia: A hospital-based study

Contact Info

Product

Resources

About